Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

DMPK News

Senior appointments enhance Sygnature Discovery’s DMPK capabilities

READ ARTICLE

News

The creation of ScanStation; drug discovery takes inspiration from supermarkets for more efficient lab management.

READ ARTICLE

News

Sygnature Discovery starts 2019 with two senior appointments: Dr Allan Jordan and Ms Louisa Jordison

READ ARTICLE

Drug Discovery News

Pathios Therapeutics and Sygnature Discovery sign strategic partnership

READ ARTICLE

Events News

Sygnature Discovery in the final of the 6th National RSC/SCI Retrosynthesis competition

READ ARTICLE

News

Sygnature Discovery establishes US Office in Cambridge, MA

READ ARTICLE

News

Towards the Holy Grail of Computational Chemistry

READ ARTICLE

Drug Discovery News

Sygnature Discovery announces multi-target drug discovery deal with Sitryx Therapeutics

READ ARTICLE

News

Dr. Scott Pollack – IDO Inhibitors and their Pharmacological Effects

READ ARTICLE

News

Dr. Scott Pollack – Intracellular Enzyme Inhibitors in Small Drug Discovery

READ ARTICLE

News

Dr. Scott Pollack – Ensuring Strong Hit-to-Lead Discovery Projects in the Future

READ ARTICLE

DMPK Drug Discovery News

Sygnature Discovery announces ambitious expansion plans with addition of Alderley Park facility

READ ARTICLE
MORE...

Upcoming Events

View All
24-26 Mar 2019

Fragments 2019: 6th RSC-BMCS Fragment-based Drug Discovery Meeting

Cambridge, UK

VISIT WEBSITE
30-01 Apr-May 2019

BioTrinity 2019

London, UK

VISIT WEBSITE
25-27 Mar 2019

BIO-Europe Spring 2019

Vienna, Austria

VISIT WEBSITE